Abstract
In mammals, TAK1, a MAPKKK kinase, is implicated in multiple signaling processes, including the regulation of NF-κB activity via the IL1-R/TLR pathways. TAK1 function has largely been studied in cultured cells, and its in vivo function is not fully understood. We have isolated null mutations in the Drosophila dTAK1 gene that encodes dTAK1, a homolog of TAK1. dTAK1 mutant flies are viable and fertile, but they do not produce antibacterial peptides and are highly susceptible to Gram-negative bacterial infection. This phenotype is similar to the phenotypes generated by mutations in components of the Drosophila Imd pathway. Our genetic studies also indicate that dTAK1 functions downstream of the Imd protein and upstream of the IKK complex in the Imd pathway that controls the Rel/NF-κB like transactivator Relish. In addition, our epistatic analysis places the caspase, Dredd, downstream of the IKK complex, which supports the idea that Relish is processed and activated by a caspase activity. Our genetic demonstration of dTAK1's role in the regulation of Drosophila antimicrobial peptide gene expression suggests an evolutionary conserved role for TAK1 in the activation of Rel/NF-κB-mediated host defense reactions.
Keywords: Innate immunity, antimicrobial peptide, rel/NF-κB, Toll, TAK1, caspase
Insects rely on multiple strategies to defend themselves against microbial infection: (a) they activate proteolytic signaling cascades that lead to melanization and coagulation reactions at injury sites and around foreign objects; (b) they utilize blood cells to either phagocytose or encapsulate invading microbes; and (c) they produce numerous antimicrobial peptides (for review, see Hoffmann and Reichhart 1997; Khush and Lemaitre 2000). Antimicrobial peptides are synthesized in the fat body (an analog of the mammalian liver) in response to systemic infections and in several epithelial tissues in response to local infections (Ferrandon et al. 1998; Tzou et al. 2000; Onfelt Tingvall et al. 2001). Seven distinct classes of peptides have been identified in Drosophila: Drosomycin, Metchnikowin, Diptericin, Drosocin, Cecropin, Defensin, and Attacin. Drosomycin is mainly active against fungi; Metchnikowin shows both antifungal and antibacterial activities; the other peptides are mainly active against bacteria (for review, see Hoffmann and Reichhart 1997). Rel/Nuclear Factor (NF)-κB-like transcription factors are the major regulators of antimicrobial peptide gene expression in Drosophila, and their activity is modulated by signaling pathways that are similar to the interleukin 1-receptor (IL1-R) in mammals (for review, see Engstrom 1999; Anderson 2000; Khush et al. 2001). These similarities indicate an evolutionary link between the control of antimicrobial peptide gene expression and the control of mammalian innate immune responses (Hoffmann et al. 1999; Aderem and Ulevitch 2000).
The Toll signaling pathway, which was first identified as a regulator of embryonic dorsal-ventral patterning, is one regulator of antimicrobial peptide gene expression (Lemaitre et al. 1996). Upon infection, the Spaetzle (Spz) protein is cleaved to generate a ligand for the Toll transmembrane receptor protein; Toll binding by Spz stimulates the degradation of the Inhibitory (I)-κB homolog, Cactus, and the nuclear translocation of the Rel proteins Dorsal and Dorsal-like immunity factor (Dif). Dorsal and Dif appear to function redundantly to regulate antimicrobial peptide gene expression in larvae, but in adults, Dif is required for Toll-mediated antimicrobial peptide gene induction (Manfruelli et al. 1999; Meng et al. 1999; Rutschmann et al. 2000a). Loss-of-function mutations in genes of the Toll signaling cascade (spz, Toll, pelle, and tube) impair the induction of the antifungal peptide gene Drosomycin, and in flies carrying a gain-of-function Toll mutation that activates the Toll pathway, Drosomycin is constitutively expressed (Lemaitre et al. 1996). Toll-deficient flies resist bacterial infections but are highly susceptible to fungal infections, demonstrating that the immune responses regulated by the Toll pathway are required to resist fungal infection (Lemaitre et al. 1996).
The second pathway regulating antimicrobial peptide gene expression in flies was initially identified by a mutation in the immune deficiency (imd) gene that results in susceptibility to Gram-negative bacterial infection and an impairment of antibacterial peptide gene expression (Lemaitre et al. 1995). imd encodes a homolog of the mammalian Receptor Interacting Protein (RIP) (P. Georgel et al., in prep.), and molecular studies have isolated four additional factors that appear to define the Imd pathway: Relish, a third Drosophila Rel protein (Hedengren et al. 1999); two members of a Drosophila IκB kinase (IKK) complex, that is, the kinase DmIKKβ and a structural component DmIKKγ (Kim et al. 2000; Rutschmann et al. 2000b; Silverman et al. 2000; Lu et al. 2001) and Dredd, a caspase (Elrod-Erickson et al. 2000; Leulier et al. 2000). Relish is a homolog of the mammalian P100 and P105 compound Rel proteins that contain both Rel domains and inhibitory ankyrin domains (Hedengren et al. 1999). A receptor for the Imd pathway has not been identified, but infection triggers Relish cleavage and nuclear translocation of the Rel domain (Stöven et al. 2000). Relish cleavage requires DmIKKβ activity, indicating that, like the mammalian IKK complex that functions in the IL1-R and TNF-R pathways, the Drosophila IKK complex regulates Rel protein activity (Silverman et al. 2000). In contrast to P100 and P105 processing, however, Relish cleavage is not blocked by proteasome inhibitors but does require a functional Dredd gene, suggesting that Dredd may cleave Relish directly after infection (Stöven et al. 2000). Like imd, mutations in DmIKKβ, DmIKKγ, Dredd, and Relish affect antibacterial peptide gene expression after infection and induce susceptibility to Gram-negative bacterial infections (Hedengren et al. 1999; Leulier et al. 2000; Rutschmann et al. 2000b; Lu et al. 2001). However, mutations in these genes do not induce susceptibility to fungal infections, demonstrating that the immune responses regulated by the Imd pathway are required to resist Gram-negative bacterial but not fungal infections (Leulier et al. 2000; Rutschmann et al. 2000b).
Some significant conclusions of recent studies on the regulation of Drosophila antimicrobial peptide gene expression are that the Toll and Imd pathways do not share any components and that each pathway regulates specific Rel proteins (Leulier et al. 2000; Rutschmann et al. 2000b; Khush et al. 2001; Lu et al. 2001). The only evidence of interactions between the two pathways is the observation that both pathways are required to fully induce some of the antimicrobial peptide genes (Lemaitre et al. 1996), suggesting that these genes respond to combinations of Rel proteins controlled by the two pathways. The influence of each pathway on the expression of each antimicrobial peptide gene is apparent in flies carrying mutations that affect either the Toll or the Imd pathway: Drosomycin is mainly controlled by the Toll pathway; Diptericin and Drosocin can be fully activated by the Imd pathway; and full Metchnikowin, Defensin, Cecropin A and Attacin activation requires both pathways (Lemaitre et al. 1996; Levashina et al. 1998). None of the antimicrobial peptide genes are induced in imd; Toll double mutant flies, demonstrating that Imd and Toll are two essential pathways that regulate antimicrobial gene expression pathways (Lemaitre et al. 1996).
Despite our increased understanding of the regulation of antimicrobial peptide gene expression in flies, various intermediates in the Toll and Imd pathways remain uncharacterized: For example, the kinase that targets Cactus for degradation in the Toll pathway and the receptor-adaptor complex that regulates the Imd pathway have not been identified. Following the observations that null mutations affecting the Imd pathway are not required for viability (Hedengren et al. 1999; Leulier et al. 2000; Rutschmann et al. 2000b; Lu et al. 2001), we initiated a search for additional members of the Imd pathway by screening for nonlethal mutations that induce susceptibility to Gram-negative bacterial infection in adult flies. We now report that null mutations in the Drosophila transforming growth factor activated kinase 1 gene (dTAK1) encoding the Drosophila homolog of the mammalian mitogen-activated protein kinase kinase kinase (MAPKKK) TAK1 (Takatsu et al. 2000) induce high susceptibility to Gram-negative bacterial infection and block antibacterial peptide gene expression. Our results indicate that dTAK1 codes for a new component of the Imd pathway.
Results
D10 is required to resist Gram-negative bacterial infection
To identify Drosophila genes that mediate defense reactions to bacterial infection, we tested ∼2500 lines carrying ethyl methanesulfonate (EMS)-induced mutations on the X chromosome for susceptibility to bacterial infection: we pricked male adult flies with a needle dipped into a pellet of the Gram-negative bacterial species Erwinia carotovora carotovora 15 (E. carotovora 15) (Basset et al. 2000) and screened for mutants that failed to survive infection. Using this assay, we isolated nine recessive, homozygous viable mutations that render flies highly susceptible to E. carotovora 15 infection: Less than 10% of the mutated flies survived 48 h postinfection, whereas more than 90% of the wild-type flies survived (data not shown). These nine mutations fall into two complementation groups: B118, which represents five of the mutations, and D10, which represents the other four mutations. The B118 group corresponds to the caspase encoding gene Dredd that we described recently (Leulier et al. 2000), and in the present report we characterize D10, the second gene isolated in our screen.
To compare the D10 phenotype with the phenotypes generated by mutations in other genes that regulate Drosophila immune responses, we first assayed the susceptibility of D10 and other mutant lines to infection by four microorganisms: we pricked flies with the Gram-negative bacteria Escherichia coli (E. coli), the Gram-positive bacteria Micrococcus luteus (M. luteus), or the fungus Aspergillus fumigatus, and we naturally infected flies with the entomopathogenic fungus Beauveria bassiana (B. bassiana) (Fig. 1). The D10 phenotype is similar to the imd and Relish phenotypes; flies carrying the D10, imd, and Relish mutations are susceptible to Gram-negative bacterial infection and resistant to Gram-positive bacterial and fungal infections, although D10 flies, like imd flies, exhibit slightly lower susceptibility to Gram-negative bacterial infection compared to Relish mutants. In contrast, mutations in the spz gene render flies susceptible to fungal infections, and only flies carrying mutations in both spz and imd are susceptible to Gram-positive bacterial infection. This survival analysis demonstrates that the D10 gene product, like Imd and Relish, is required to resist Gram-negative bacterial infection.
D10 regulates antibacterial peptide gene expression
The Toll pathway is required for the full induction of the antifungal peptide genes and a subset of the antibacterial peptide genes. Mutations that block the Toll pathway reduce the expression of these genes; conversely, mutations that block the Imd pathway reduce the expression of genes with antibacterial activity (for review, see Engstrom 1999; Khush et al. 2001). To determine how the D10 mutation affects antimicrobial peptide gene expression, we monitored the levels of Diptericin, Cecropin A, Defensin, and Attacin, which encode antibacterial peptides, Drosomycin, which encodes an antifungal peptide, and Metchnikowin, which encodes a peptide with both antibacterial and antifungal activity (Hoffmann and Reichhart 1997), in flies homozygous for two D10 alleles. In addition, we compared the D10 phenotype with all of the previously identified mutations affecting the Imd pathway and with a spz mutation that blocks the Toll pathway.
Pricking adult flies with a mixture of Gram-positive and Gram-negative bacteria activates the expression of all the antimicrobial peptide genes; in the D10 mutants, however, mixed Gram-negative/Gram-positive infections induce significant levels of only Drosomycin and Metchnikowin (Fig. 2A,B). Quantitative measurements of three independent RNA blot experiments show that in D10 flies, Drosomycin is induced to wild-type levels, Metchnikowin is induced to 70% of wild-type levels, Cecropin A, Defensin, and Attacin are induced to <25% of wild-type levels, and Diptericin is induced to <5% of wild-type levels (Fig. 2B). This pattern of antimicrobial peptide gene expression in the D10 mutants is similar to the patterns displayed in mutants of the Imd pathway, although the D10 mutations, like imd, have slightly weaker effects on antimicrobial peptide gene expression compared to the Dredd, DmIKKβ, DmIKKγ, and Relish mutations (Fig. 2A) (Lemaitre et al. 1995; Hedengren et al. 1999; Leulier et al. 2000; Rutschmann et al. 2000b; Lu et al. 2001). This weaker phenotype in D10 and imd flies correlates well with their lower susceptibility to E. coli infection (Fig. 1).
D10 does not function in the Toll pathway
In contrast to the infections induced by pricking flies with mixtures of Gram-negative and Gram-positive bacteria, natural infections by the fungus B. bassiana selectively induce the expression of Drosomycin and Metchnikowin via the Toll pathway (Lemaitre et al. 1997). To determine whether D10 plays a role in the Toll pathway, we compared Drosomycin expression in different mutant backgrounds after fungal infection. We found that in contrast to mutations in spz, mutations in D10 and components of the Imd pathway do not block Drosomycin induction (Fig. 3A); the variable Drosomycin levels in the different Imd pathway mutants are probably due to differing efficiencies of natural infection. Furthermore, mutations in D10 and Dredd do not block the constitutive Drosomycin expression induced by the dominant, gain-of-function Toll10B mutation (Lemaitre et al. 1996) (Fig. 3B). The Toll and Imd pathways are the two major regulators of antimicrobial peptide gene expression in Drosophila, and flies carrying mutations in both the Toll and Imd pathways do not express any antimicrobial peptide genes (Lemaitre et al. 1996). Similarly, flies carrying spz in combination with either D10 or Dredd mutations fail to express any of the antimicrobial peptide genes after a mixed bacterial infection (Fig. 3C). We noted only a residual expression of the Drosomycin gene in the double mutant. The D10 phenotypes that we have characterized, that is, susceptibility to Gram-negative bacterial infection, reduced induction of the antibacterial peptide genes, absence of detectable function in the Toll pathway, and a complete block of antimicrobial peptide gene expression in combination with a spz mutation, are identical to the phenotypes generated by mutations in members of the Imd pathway, suggesting that D10 encodes a novel component of the Imd pathway.
D10 encodes the MAPKKK dTAK1
Using susceptibility to Gram-negative bacterial infection as an assay, we first mapped D10 by recombination to a region of the X chromosome distal to forked (data not shown). Deficiencies and additional genetic markers enabled us to further localize D10 to a portion of the cytogenetic interval 19E1 that, based on genomic annotation data (Consortium 1998), contains ∼25 genes (Fig. 4A). One of the 25 genes in this region is dTAK1, which encodes a homolog of the mammalian TAK1 gene product (Takatsu et al. 2000). In mammals, TAK1 is implicated in the regulation of NF-κB as a component of the IL-1 signaling pathway, where it is thought to function upstream of the IKK complex (Sakurai et al. 1998; Ninomiya-Tsuji et al. 1999; Sakurai et al. 1999; Irie et al. 2000). Based on the established roles of an IKK complex and the NF-κB-like transactivator Relish in the Imd pathway, we selected dTAK1 as a candidate for D10.
We performed several different experiments to determine whether the D10 alleles correspond to mutations in dTAK1. First, we tested the ability of a 15 Kb genomic fragment that contains dTAK1 and annotation CG1812 (Fig. 4B) to rescue the immune response deficiency in D10 flies. Figures 4C and D show that D10 adults carrying the dTAK1 transgene (P[dTAK1+]) both express Diptericin and resist Gram-negative bacterial infection at levels comparable to wild-type flies, demonstrating that this genomic fragment rescues the D10 phenotypes. We also determined that overexpression of the dTAK1 cDNA using the UAS/GAL4 system partially rescues Diptericin expression in the D101 mutant (Fig. 6A, see below). We next sequenced the three Kb of dTAK1 genomic coding sequence in our original y,w strain and in each of the four homozygous D10 lines. The four D10 alleles all contain mutations within the dTAK1 kinase domain, which led us to rename the D10 alleles dTAK11 to dTAK14: dTAK11 and dTAK14 were generated by missense mutations in conserved residues, dTAK12 was generated by a point mutation that creates a stop codon, and dTAK13 contains a deletion of 31 base pairs that also results in a premature stop codon (Fig. 5A,B). All four dTAK1 alleles inhibit Diptericin induction by Gram-negative bacterial infection to the same degree (Fig. 4C), and this inhibition is not enhanced in flies heterozygous for each allele and a deficiency spanning dTAK1 (data not shown). In addition, flies homozygous for the four alleles are equally susceptible to Gram-negative bacterial infection (data not shown). The apparent null phenotype manifested by the four dTAK1 alleles indicates that the dTAK1 kinase domain is essential for dTAK1 function in the Imd pathway. This observation is supported by results from our experiments with a kinase dead form of dTAK1, dTAK1-K46R, which was previously reported to act as a dominant negative inhibitor of dTAK1 (Takatsu et al. 2000). dTAK1-K46R expression driven by the UAS/GAL4 system (Brand and Perrimon 1993) blocks Diptericin expression after mixed bacterial infection, confirming that dTAK1 is required for the Drosophila antibacterial immune response (Fig. 4C). The results of our rescue experiments, our sequencing data, and the dominant negative dTAK1 mutant phenotypes together demonstrate that D10 encodes the MAPKKK dTAK1.
dTAK1 functions upstream and Dredd functions downstream of the Drosophila IKK complex
The loss-of-function dTAK1 mutations that we isolated display immune response phenotypes that are very similar to the phenotypes generated by mutations in imd, DmIKKβ, DmIKKγ, Dredd, and Relish, suggesting that these genes function together in the Imd pathway. Previous studies indicated that DmIKKγ and DmIKKβ directly regulate Relish activity (Silverman et al. 2000); however, the positions of Imd, dTAK1, and Dredd in the Imd pathway were not determined. Double mutant analysis combining a Toll gain-of-function mutation that constitutively activates the Toll pathway and loss-of-function mutations in other genes was a powerful tool for establishing the order of action of the genes encoding components of the Toll pathway (for review, see Belvin and Anderson 1996). Unfortunately, none of the mutations affecting the Imd pathway produce constitutive antibacterial immune responses; consequently, to avail of a genetic approach for ordering the Imd pathway, we overexpressed both Dredd and dTAK1 via the UAS/GAL4 system. In lines carrying a heat shock (hs)-GAL4 driver and either the Dredd or dTAK1 cDNAs under the control of a UAS promoter, heat shock induces Diptericin expression to about 15–20% of the level observed in adults 6 h after bacterial infection (Fig. 6A). This result indicates that the overexpression of these two genes is sufficient to activate the antibacterial pathway in the absence of infection. By using this UAS/GAL4 system to overexpress dTAK1 and Dredd in various mutant backgrounds, we tested the epistatic relationships between dTAK1 and Dredd, and the other genes of the Imd pathway. Figure 6A shows that mutations in DmIKKβ and DmIKKγ, but not imd, block Diptericin induction by dTAK1 overexpression, indicating that dTAK1 functions downstream of Imd and upstream of the IKK complex. However, the Diptericin expression induced by Dredd overexpression was not affected by mutations in imd or DmIKKγ. For genetic reasons, we were unable to use Northern blot analysis to test the effect of mutations in Relish and DmIKKβ, which are on the third chromosome, on the UAS-Dredd-induced Diptericin expression. Therefore, we overexpressed the UAS-Dredd transgene through a female, adult fat body driver (yolk-GAL4) and monitored Diptericin expression with a Diptericin-LacZ reporter gene (Fig. 6B). LacZ titration assays demonstrate that β-galactosidase activity is induced in lines overexpressing UAS-Dredd in the absence of infection. The Dredd-mediated Diptericin-LacZ induction was strongly reduced in Relish but not in DmIKKβ mutants, confirming our Northern blot results showing that Dredd functions downstream of the IKK complex and demonstrating that Dredd regulates Diptericin expression through Relish.
Natural Gram-negative bacterial infection selectively activates the Imd pathway
Natural fungal infections highlight the ability of Drosophila to discriminate between pathogens and activate specific immune response pathways that lead to adapted immune responses (for review, see Khush and Lemaitre 2000). Although only the Imd pathway is required to resist Gram-negative bacterial infection, the Toll pathway is still activated to some degree in flies pricked with Gram-negative bacteria (Lemaitre et al. 1997). This suggests that injury (and associated contamination) contributes to a nonspecific immune response. We recently demonstrated that E. carotovora 15 naturally infects the Drosophila larval gut and triggers both the local and systemic expression of antimicrobial peptide genes (Basset et al. 2000; Tzou et al. 2000). In contrast to infection by pricking, natural E. carotovora 15 infection induces Diptericin expression more strongly than Drosomycin expression (Basset et al. 2000). To compare the contribution of the Toll and Imd pathways to antimicrobial peptide induction after natural E. carotovora 15 infection, we quantified Diptericin and Drosomycin expression in larvae from various mutant lines after natural E. carotovora 15 infections. Figure 7 shows that the Diptericin expression induced by E. carotovora 15 natural infection is entirely dependent on the genes of the Imd pathway, confirming that Diptericin is exclusively regulated by the Imd pathway. Interestingly, the level of Diptericin induction was higher in spz mutants than in wild-type larvae. In addition, Drosomycin induction after E. carotovora 15 natural infection of larvae was also dependent on the Imd pathway: mutations blocking the Imd pathway have stronger affects than the spz mutation on Drosomycin expression induced by natural infection. These data contrast somewhat with our previously published observation that the imd mutation did not block Drosomycin induction by E. carotovora 15 infection (Basset et al. 2000). However, our first analysis of Drosomycin induction by E. carotovora 15 was based on the qualitative analysis of a Drosomycin-lacZ reporter gene; we believe that the quantitative analysis of Drosomycin expression by Northern blot is a more accurate determination of Drosomycin expression patterns. In conclusion, our current results indicate that Drosomycin gene induction after natural Gram-negative bacterial infection is largely mediated by the Imd pathway.
Natural infections by E. carotovora 15 also trigger the local expression of antimicrobial peptide genes in various epithelial tissues, and both Diptericin expression in the anterior midgut and Drosomycin expression in the trachea are dependent on the imd gene (Ferrandon et al. 1998; Tzou et al. 2000). By assaying the expression of Diptericin-lacZ and Drosomycin-GFP reporter genes in naturally infected dTAK1 and Dredd mutant larvae, we now show that both genes are required for Diptericin and Drosomycin expression in epithelial tissues after natural E. carotovora 15 infection (Fig. 8). These data confirm the predominant role of the Imd pathway in antimicrobial peptide regulation after natural E. carotovora 15 infection and suggest that Gram-negative bacterial recognition in flies preferentially activates the Imd pathway.
Discussion
The Drosophila homolog of TAK1 regulates antibacterial defense
Mammalian TAK1 was initially identified by a complementation assay in yeast for its ability to substitute for the MAPKKK Ste11p in the yeast MAPK pheromone pathway (Yamaguchi et al. 1995). TAK1 is a MAPKKK and contains a protein kinase domain in its N-terminal region that is ∼30% identical to the catalytic domains of RAF1 and MEKK1. In mammals, TAK1 function has been extensively studied in transient transfection assays using cultured cells (for review, see Behrens 2000). These studies indicate that TAK1 can function in a signal transduction pathway that is triggered by the TGFβ superfamily of ligands. In addition, the overexpression of Xenopus TAK1 and an upstream activator called TAB1 induce embryonic ventralization. Studies of dominant negative mutant forms of TAK1 place TAK1 activity downstream of the BMP2/4 receptors (Shibuya et al. 1998).
Besides TGFβ signaling, TAK1 appears to be involved in various other signal transduction pathways. Cell culture experiments indicate that ceramide stimulates the TAK1 kinase activity and that ceramide-induced JNK/SAPK activation is blocked by a dominant negative TAK1 mutant (Shirakabe et al. 1997). Biochemical studies also show that MAPKK4 and MAPKK3/MAPKK6 can be phosphorylated by TAK1, suggesting that TAK1 can activate the JNK pathway and/or the P38 MAPK pathways (Moriguchi et al. 1996; Wang et al. 1997), and other experiments demonstrate interactions between TAK1 and the Wnt signaling pathway (Ishitani et al. 1999). Several studies have pointed toward a role for TAK1 in the IL1-R/NF-κB signaling pathway (Sakurai et al. 1998; Ninomiya-Tsuji et al. 1999; Sakurai et al. 1999). Dominant negative TAK1 mutants prevent NF-κB activation by IL1 or the TLRs (Ninomiya-Tsuji et al. 1999; Irie et al. 2000), and TAK1 appears to activate NF-κB by stimulating the IκB kinase complex (IKK) that induces IκB degradation by the proteasome (Ninomiya-Tsuji et al. 1999; Sakurai et al. 1999). Furthermore, TAK1 interacts with TRAF6, which is a downstream effector of the IL1 receptor, suggesting that TAK1 links TRAF6 to the NIK-IKK cascade in the IL1-R/TLR signaling pathways (Ninomiya-Tsuji et al. 1999).
A Drosophila homolog of TAK1, dTAK1, that possesses an extensively conserved NH2-terminal kinase and a partially conserved C-terminal domain was identified recently (Takatsu et al. 2000). Ectopic dTAK1 expression induces apoptosis, whereas overexpression of a dominant negative form of dTAK1 during development results in various cuticle defects, some of which are similar to those observed in mutants in JNK signaling. This preliminary analysis suggested a role for dTAK1 in the regulation of apoptosis and JNK signaling in flies (Takatsu et al. 2000; Mihaly et al. 2001). In the present study, we isolated four null mutations in dTAK1. Each of these mutations affects the kinase domain of dTAK1, generating either a premature stop codon or an amino acid substitution. Flies deficient for dTAK1 are highly susceptible to Gram-negative bacterial infection and fail to express antibacterial peptide-encoding genes after infection. This dTAK1 phenotype is identical to the phenotype induced by mutations affecting components of the Imd pathway, suggesting that dTAK1 is a new component of the Imd pathway. dTAK1 does not, however, function in the Toll pathway that mediates dorsal-ventral patterning and antifungal immune responses in flies; the dTAK1 mutations do not affect the Toll-mediated Drosomycin induction by fungal infection or the constitutive Drosomycin expression in Toll gain-of-function mutants, and the dTAK1 mutants are not susceptible to fungal infection. Surprisingly, our results indicate that, in contrast to TGFβ- or JNK signaling-defective mutants, dTAK1 flies are viable and do not display obvious developmental defects. The developmental phenotypes generated by overexpressing a dominant negative form of TAK1 (Takatsu et al. 2000; Mihaly et al. 2001) were not observed in the dTAK1-deficient mutants, although we have shown that the dominant negative dTAK1 mutant does phenocopy the dTAK1 mutant immune phenotype. Our results demonstrate that dTAK1 is either not involved in JNK and TGFβ signaling in Drosophila or that its function in these pathways is redundant with another MAPKKK.
Ordering the Imd pathway
Overexpressing dTAK1 or Dredd via the UAS/GAL4 system leads to weak but consistent Diptericin expression in the absence of infection, indicating that overexpressing these two genes is sufficient to turn on the antibacterial pathway. The constitutive Diptericin expression in the dTAK1 and Dredd overexpression lines also allowed us to analyze the epistatic relationship between dTAK1, Dredd, and the other recently identified regulators of antibacterial defense, and, in agreement with their similar mutant phenotypes, our results confirm that Imd, dTAK1, the DmIKK complex, and Dredd function in a pathway that culminates in Relish activation (Fig. 9). Our data suggest a model in which Imd functions upstream of dTAK1 and is the most upstream component currently identified in the Imd pathway. The imd gene was recently cloned and encodes a death domain-containing protein with homology to the mammalian RIP (P. Georgel et al., in prep.). In mammals, RIP appears to function in an adaptor complex associated with the tumor necrosis factor (TNF) receptor, and our genetic placement of imd suggests that IMD has a conserved function in flies as part of a receptor-adaptor complex that responds to Gram-negative bacterial infection (Fig. 9).
Our epistatic analysis also indicates that dTAK1 functions upstream of the DmIKK complex. In mammals, TAK1 functions upstream of the IKK complex, and it is not yet clear whether TAK1 directly activates the IKK complex (Sakurai et al. 1999) or whether TAK1 functions through NIK, another MAPKKK that is involved in NF-κB regulation (Ninomiya-Tsuji et al. 1999). A strong NIK homolog is not apparent in the Drosophila genome (Khush and Lemaitre 2000), suggesting that dTAK1 may directly activate the DmIKK complex after infection. dTAK1 flies have slightly weaker phenotypes than DmIKKβ, DmIKKγ, Dredd, and Relish mutants, and this may correlate with the function of dTAK1 at an early stage of the antibacterial cascade where multiple inputs, some of which bypass dTAK1, regulate the DmIKK complex.
Dredd encodes a caspase with a large prodomain and is related to mammalian Caspase 8 (Rodriguez et al. 1999). Our genetic analysis indicates that Dredd functions downstream of the DmIKK complex and induces Diptericin expression through Relish, which confirms previous observations by Stöven et al. (2000), who showed that after infection Relish is rapidly cleaved by a proteasome-independent mechanism and that this cleavage is blocked in Dredd mutants. There is increasing evidence that caspases are involved in physiological processes other than apoptosis, and Dredd function downstream of the DmIKK complex suggests that Dredd participates directly, or indirectly via an effector caspase, in Relish cleavage. In mammals, apical caspases are activated by the processing of a prodomain, and a future issue to address is whether Dredd is constitutively active or is regulated by the DmIKK complex or another upstream component of the Imd pathway.
Independent activation of the Toll and Imd pathways
A current view of the antimicrobial response in Drosophila is that the induction of the antimicrobial peptides are controlled by two distinct pathways, Toll and Imd, that each regulate specific rel/NF-κB proteins (Leulier et al. 2000; Rutschmann et al. 2000b; Khush et al. 2001). These pathways are the two main immunoresponsive signaling cascades, as illustrated by our observation that flies carrying a mutation in both pathways fail to express any antimicrobial peptide genes and are highly susceptible to infection by all types of microorganisms. The ability to differentiate between microbes and activate each of these pathways independently, in response to different types of infection, appears to be one mechanism for mounting adapted immune responses. For example, the specific induction of Drosomycin after natural infection by the entomopathogenic fungus B. bassiana is due to the selective activation of the Toll pathway since, as indicated by our present results, this induction is not affected by mutations that block the Imd pathway. Natural infection by the Gram-negative bacterial species E. carotovora 15 leads to a predominant expression of antibacterial rather than antifungal peptide genes, and reveals the ability of Drosophila to mount adapted innate immune responses to Gram-negative bacterial infection (Basset et al. 2000). Our present findings indicate that antimicrobial peptide gene expression after natural E. carotovora 15 infections is largely mediated through the Imd pathway, and that both Diptericin and Drosomycin expression after E. carotovora 15 infection are impaired in mutants affecting components of the Imd pathway. The high level of Diptericin expression and the low level of Drosomycin expression observed in this context probably reflect the differential responses of these two target genes to the selective activation of the Imd pathway. In the trachea, a major site of infection in insects, natural infection by E. carotovora 15 triggers Drosomycin gene expression in an Imd-dependent manner (Tzou et al. 2000; present finding). This illustrates the ability of the Drosomycin gene to be weakly turned on in response to Gram-negative bacterial infection by the Imd pathway, independently of any Toll input.
Interactions between the Toll and Imd pathways
Except for Diptericin and Drosocin, all of the antimicrobial peptide genes are regulated by inputs from both the Toll and Imd pathways; some, like Defensin, require the concomitant activation of both pathways, while others, such as Drosomycin and Metchnikowin, can be induced independently by each of these pathways (Lemaitre et al. 1996; Levashina et al. 1998). One hypothesis is that the differential regulation of antimicrobial peptide genes reflects their sensitivity to specific combinations of the Rel proteins that are the end targets of the Toll and Imd pathways (Han and Ip 1999). For example, Diptericin induction after infection is fully dependent on Relish and is not altered in mutants deficient for both Dif and Dorsal activity (Hedengren et al. 1999; Manfruelli et al. 1999; Meng et al. 1999). In agreement, Diptericin gene expression is almost completely abolished in mutants deficient in Imd signaling. Interestingly, we observed that the level of Diptericin gene expression is higher in spz mutant larvae than in wild-type larvae after natural Gram-negative bacterial infection (Fig. 7), and we observed a similar response after mixed Gram-negative/Gram-positive bacterial infection in adult flies (Fig. 2A). These observations are consistent with our previous studies of Diptericin expression in spz mutants, although those results were not highlighted earlier (Fig. 2 in Lemaitre et al. 1996; Fig. 2A in Leulier et al. 2000). The effect of the spz mutation on Diptericin induction points to a negative effect of the Toll pathway on this gene. Our hypothesis is that Relish homodimers are the most potent activators of Diptericin, and that by blocking Dif and Dorsal activation, mutations in the Toll pathway may increase the formation of Relish homodimers versus Relish-Dif or Relish-Dorsal heterodimers. Together these observations indicate how the differential activation of these two pathways leads in a subtle way to the preferential expression of specific target genes.
Concluding remarks
We describe here the identification of null mutations in the Drosophila homolog of TAK1. Our genetic analysis shows that dTAK1, like the other components of the Imd pathway, is required for the induction of antibacterial peptide gene expression, and dTAK1's role in the Drosophila immune response is highlighted by the strong susceptibility of dTAK1 mutants to Gram-negative bacterial infection. In mammals, experiments with tissue cultured cells indicate a role for TAK1 in the IL1-R/TLR-NF-κB pathway that regulates innate immune response. These data, and the results of our genetic studies of flies, suggest that the role of this MAPKKK in the control of the rel/NF-κB innate immune response has been conserved during evolution, thereby strengthening the parallels between the regulation of mammalian and Drosophila innate immune responses. The list of common factors used by flies and mammals to regulate rel/NF-κB proteins has increased in the last few years, but as shown for dTAK1 here, it appears that the regulators that function in the IL1/TLR pathway in mammals function independently in either the Toll or Imd in Drosophila. The existence of two distinct pathways for regulating NF-κB in flies may allow for the production of specific subsets of antimicrobial peptides against different pathogens (Khush et al. 2001).
We identified dTAK1 in a screen for X-linked genes in Drosophila that are required to resist Gram-negative bacterial injection. Our findings illustrate the power of Drosophila genetics, since survival against challenge is a simple screen for genes involved in the Drosophila immune response. However, it is striking that among the 2500 mutagenized lines that we tested for susceptibility to Gram-negative bacterial infection, only mutations in Dredd and dTAK1, two components of the Imd pathway, were identified. This result suggests that the Imd pathway controls the most important mechanisms for combating Gram-negative bacterial infection in flies.
Materials and methods
Drosophila strains
CantonS flies were used as a wild-type standard. imd, spz, and Tl alleles are described elsewhere (Lemaitre et al. 1996). RelishE20, DreddB118, DmIKKβird5 (ird51), and DmIKKγkey1 (kenny1) are either strong or null alleles of Relish, Dredd, DmIKKβ, and DmIKKγ (Hedengren et al. 1999; Leulier et al. 2000; Rutschmann et al. 2000b; Lu et al. 2001). dTAK11 (D101), dTAK12 (D102), dTAK13, and dTAK14 are four EMS-induced mutations of dTAK1 that were generated in a yw chromosome. Diptericin-lacZ is a P transgene containing a fusion between 2.2 kb of upstream sequence from the Diptericin gene and the coding sequences from the β-galactosidase gene (Tzou et al. 2000). Drosomycin-GFP is a P transgene containing a fusion between 2.4 kb of upstream sequence from the Drosomycin gene and the coding sequences from the Green Fluorescent Protein gene (Ferrandon et al. 1998). The precise fly genotypes are: imd: br, pr, imd; spzrm7: spzrm7/spzrm7; Relish: RelishE20, e; DreddB118: y,w, DreddB118; dTAK1: y,w, dTAK1; DmIKKβird5: DmIKKβird5, ca, Diptericin-lacZ; DmIKKγkey1: y,w, Diptericin-lacZ, Drosomycin-GFP; cn,bw, sp, DmIKKγkey1. For survival studies, we used a RelishE20 stock from which the ebony mutation was removed, because ebony affects survival levels (Lemaitre et al. 1996). Drosophila stocks were maintained at 25°C. After infection, flies were incubated at either 25°C for Northern blots or 29°C for survival assays.
Mutagenesis
y, w male flies were treated with 25 mM EMS. The mutagenized males were crossed with females C(1)DX y, w, f, and single F1 males were back-crossed to the same female stock to establish independent lines. Six F2 males from each line were pricked with a needle dipped in a concentrated pellet of E. carotovora 15 (OD = 200), and incubated at 29°C overnight. Lines that showed more than four dead flies out of six were retested. CantonS and imd flies were used as internal controls. For each selected line, a homozygous stock was established by crossing F2 males with FM3/l(1)44ter females. Survival after Gram-negative bacterial infection was sufficiently reliable to establish complementation groups. Initial mapping was performed by monitoring resistance to E. carotovora 15 infection in recombinants between the mutated chromosome and a chromosome carrying the y+, cv, f markers. Additional mapping was done with the X chromosome deficiency kit from the Bloomington stock center.
Infection experiments
Bacterial infections were performed by pricking third instar larva or adults with a thin needle previously dipped into a concentrated culture (O.D ∼200) of E.coli, M. luteus, or a mixture of the two bacteria. Natural infections with B. bassiana were performed by shaking anesthetized flies for thirty seconds in a Petri dish containing a sporulating fungal culture (Lemaitre et al. 1997). Bacterial and fungal strains were previously described (Lemaitre et al. 1997). Natural infection by E. carotovora 15 were performed by incubating Drosophila larvae in a mixture of crushed banana and bacteria (Basset et al. 2000).
Overexpression studies
UAS-dTAK1 and UAS-dTAK1-K46R have been described previously (Takatsu et al. 2000). UAS-dTAK1-K46R encodes a dominant negative form of dTAK1 in which lysine 46 was replaced by an arginine. The full-length Dredd isoform δ* cDNA was cloned as a XhoI–BamH1 fragment from pMT-Dreddδ*-Myc (Rodriguez et al. 1999) into XhoI–BamH1 digested pUAST vector. W1118 flies were transformed using P element-mediated transformation. The yolk-GAL4 driver strongly expresses GAL4 in the female adult fat body (J.M. Reichhart, pers. comm.). The hsp70–GALl4 driver expresses GAL4 ubiquitously after heat shock.
Northern blot analysis
Total RNA extraction and Northern blotting experiments were performed as described (Lemaitre et al. 1997).
Sequencing of dTAK1 alleles
Genomic DNA from the y,w strain and the four dTAK1 mutants was extracted from single adult flies as described (Gloor and Engels 1992). One microliter of genomic DNA was used for each PCR amplification. Specific oligonucleotide primers for the dTAK1 gene were synthesized and used to amplify overlapping fragments of the dTAK1 coding sequence. The resulting single-fragment PCR products were purified using a Qiagen purification column and sequenced using the BigDye Terminator Cycle sequencing ready reaction (PE Applied Biosystems). The sequence profiles were analyzed on Edit View 1.0.1 ABI Prism (PE Applied Biosystems) and compared to the dTAK1 cDNA sequence published previously.
Cloning and transformation of P[dTAK1]
A P1 Drosophila filter (Genome Systems) was hybridized with a 32P-labeled 3.5 kb dTAK1 cDNA probe. Three clones were isolated, and one of them (DS08905) was used for the following experiments. The dTAK1 coding region (10.0 kb and 5.8 kb BamH1 fragments and a 2.6 kb EcoRI fragment) was subcloned into pBlueScriptII KS+ and sequenced using synthetic sequence primers. Drosophila Genome Project sequencing data, AC014558, (BDGP) was also used to confirm the genomic sequencing. A 15 kb genomic fragment that contains dTAK1 coding region as well as 2.5 kb 5′- and 4.8 kb 3′-untranslated regions were amplified by PCR with Takara LA Taq (Takara Biomedical) by using PCR primers. This genomic fragment was digested with XhoI and NotI and then subcloned into the Drosophila transformation vector P{CaSpeR-4}. Flies bearing transgenes were generated by general P-element mediated transformation.
Acknowledgments
We thank Kathryn Anderson, Dominique Ferrandon, and Anthony Rodriguez for providing fly stocks or plasmids and our colleagues Isaline Rowe, Stéphanie Gobin, Brigitte Maroni, Thomas Ranson, Ennio de Gregorio, and Pedro Santamaria for assistance and stimulating discussions. We are especially grateful to Jean Marc Reichhart for providing the yolk–Gal4 line prior to publication. S.V. was supported by Praxis XXI/BD/21915/99 (Portugal). M.N. thanks Dr. N. Ueno for providing laboratory space and supplies as well as valuable advice and Dr. H. Takatsu for his contribution to an earlier stage of the work. This project was funded by ATIPE CNRS, the Fondation pour la Recherche Médicale (FRM) and Programme Microbiologie (PRMMIP98).
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 USC section 1734 solely to indicate this fact.
Footnotes
E-MAIL lemaitre@cgm.cnrs-gif.fr; FAX 33-1-69-82-43- 86.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.203301.
References
- Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782–787. doi: 10.1038/35021228. [DOI] [PubMed] [Google Scholar]
- Anderson KV. Toll signaling pathways in the innate immune response. Curr Opin Immunol. 2000;12:13–19. doi: 10.1016/s0952-7915(99)00045-x. [DOI] [PubMed] [Google Scholar]
- Basset A, Khush R, Braun A, Gardan L, Boccard F, Hoffmann J, Lemaitre B. The phytopathogenic bacteria, Erwinia carotovora, infects Drosophila and activates an immune response. Proc Natl Acad Sci. 2000;97:3376–3381. doi: 10.1073/pnas.070357597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Behrens J. Cross-regulation of the Wnt signalling pathway: A role of MAP kinases J. Cell Sci. 2000;113:911–919. doi: 10.1242/jcs.113.6.911. [DOI] [PubMed] [Google Scholar]
- Belvin MP, Anderson KV. A conserved signaling pathway: The Drosophila toll-dorsal pathway Annu. Rev Cell Dev Biol. 1996;12:393–416. doi: 10.1146/annurev.cellbio.12.1.393. [DOI] [PubMed] [Google Scholar]
- Brand AH, Perrimon N. Targeted gene expression as a mean of altering cell fates and generating dominant phenotypes. Development. 1993;118:401–415. doi: 10.1242/dev.118.2.401. [DOI] [PubMed] [Google Scholar]
- Consortium TF. FlyBase—A Drosophila database. Nucleic Acids Res. 1998;26:85–88. doi: 10.1093/nar/26.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elrod-Erickson M, Mishra S, Schneider D. Interactions between the cellular and humoral immune responses in Drosophila. Curr Biol. 2000;10:781–784. doi: 10.1016/s0960-9822(00)00569-8. [DOI] [PubMed] [Google Scholar]
- Engstrom Y. Induction and regulation of antimicrobial peptides in Drosophila. Dev Comp Immunol. 1999;23:345–358. doi: 10.1016/s0145-305x(99)00016-6. [DOI] [PubMed] [Google Scholar]
- Ferrandon D, Jung AC, Criqui M, Lemaitre B, Uttenweiler-Joseph S, Michaut L, Reichhart J, Hoffmann JA. A Drosomycin–GFP reporter transgene reveals a local immune response in Drosophila that is not dependent on the Toll pathway. EMBO J. 1998;17:1217–1227. doi: 10.1093/emboj/17.5.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gloor GB, Engels WR. Single-fly DNA preps for PCR. Drosoph Inf Serv. 1992;75:148–149. [Google Scholar]
- Han ZS, Ip YT. Interaction and specificity of Rel-related proteins in regulating Drosophila immunity gene expression. J Biol Chem. 1999;274:21355–21361. doi: 10.1074/jbc.274.30.21355. [DOI] [PubMed] [Google Scholar]
- Hedengren M, Asling B, Dushay MS, Ando I, Ekengren S, Wihlborg M, Hultmark D. Relish, a central factor in the control of humoral but not cellular immunity in Drosophila. Mol Cell. 1999;4:827–837. doi: 10.1016/s1097-2765(00)80392-5. [DOI] [PubMed] [Google Scholar]
- Hoffmann J, Reichhart J. Drosophila immunity. Trends Cell Biol. 1997;7:309–316. doi: 10.1016/S0962-8924(97)01087-8. [DOI] [PubMed] [Google Scholar]
- Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999;284:1313–1318. doi: 10.1126/science.284.5418.1313. [DOI] [PubMed] [Google Scholar]
- Irie T, Muta T, Takeshige K. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages. FEBS Lett. 2000;467:160–164. doi: 10.1016/s0014-5793(00)01146-7. [DOI] [PubMed] [Google Scholar]
- Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, et al. The TAK1–NLK–MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF. Nature. 1999;399:798–802. doi: 10.1038/21674. [DOI] [PubMed] [Google Scholar]
- Khush RS, Lemaitre B. Genes that fight infection: What the Drosophila genome says about animal immunity. Trends Genet. 2000;16:442–449. doi: 10.1016/s0168-9525(00)02095-3. [DOI] [PubMed] [Google Scholar]
- Khush RS, Leulier F, Lemaitre B. Drosophila immunity: Two paths to NF-κB. Trends Immunol. 2001;22:260–264. doi: 10.1016/s1471-4906(01)01887-7. [DOI] [PubMed] [Google Scholar]
- Kim YS, Han SJ, Ryu JH, Choi KH, Hong YS, Chung YH, Perrot S, Raibaud A, Brey PT, et al. Lipopolysaccharide-activated kinase, an essential component for the induction of the antimicrobial peptide genes in Drosophila melanogaster cells. J Biol Chem. 2000;275:2071–2079. doi: 10.1074/jbc.275.3.2071. [DOI] [PubMed] [Google Scholar]
- Lemaitre B, Kromer-Metzger E, Michaut L, Nicolas E, Meister M, Georgel P, Reichhart J, Hoffmann J. A recessive mutation, immune deficiency (imd), defines two distinct control pathways in the Drosophila host defense. Proc Natl Acad Sci. 1995;92:9365–9469. doi: 10.1073/pnas.92.21.9465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lemaitre B, Nicolas E, Michaut L, Reichhart J, Hoffmann J. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996;86:973–983. doi: 10.1016/s0092-8674(00)80172-5. [DOI] [PubMed] [Google Scholar]
- Lemaitre B, Reichhart J, Hoffmann J. Drosophila host defense: Differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc Natl Acad Sci. 1997;94:14614–14619. doi: 10.1073/pnas.94.26.14614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leulier F, Rodriguez A, Khush RS, Chen P, Abrams JM, Lemaitre B. The Drosophila caspase Dredd is required to resist Gram-negative bacterial infection. EMBO Rep. 2000;1:353–358. doi: 10.1093/embo-reports/kvd073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levashina E, Ohresser S, Lemaitre B, Imler J. Two distinct pathways can control expression of the Drosophila antimicrobial peptide Metchnikowin. J Mol Biol. 1998;278:515–527. doi: 10.1006/jmbi.1998.1705. [DOI] [PubMed] [Google Scholar]
- Lu Y, Wu LP, Anderson KV. The antibacterial arm of the Drosophila innate immune response requires an IκB kinase. Genes & Dev. 2001;15:104–110. doi: 10.1101/gad.856901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manfruelli P, Reichhart JM, Steward R, Hoffmann JA, Lemaitre B. A mosaic analysis in Drosophila fat body cells of the control of antimicrobial peptide genes by the Rel proteins Dorsal and DIF. EMBO J. 1999;18:3380–3391. doi: 10.1093/emboj/18.12.3380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meng X, Khanuja BS, Ip YT. Toll receptor-mediated Drosophila immune response requires Dif, an NF-κB factor. Genes & Dev. 1999;13:792–797. doi: 10.1101/gad.13.7.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mihaly J, Kockel L, Gaengel K, Weber U, Bohmann D, Mlodzik M. The role of the Drosophila TAK homologue dTAK during development. Mech Dev. 2001;102:67–79. doi: 10.1016/s0925-4773(01)00285-4. [DOI] [PubMed] [Google Scholar]
- Moriguchi T, Kuroyanagi N, Yamaguchi K, Gotoh Y, Irie K, Kano T, Shirakabe K, Muro Y, Shibuya H, Matsumoto, et al. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem. 1996;271:13675–13679. doi: 10.1074/jbc.271.23.13675. [DOI] [PubMed] [Google Scholar]
- Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 1999;398:252–256. doi: 10.1038/18465. [DOI] [PubMed] [Google Scholar]
- Onfelt Tingvall T, Roos E, Engstrom Y. The imd gene is required for local Cecropin expression in Drosophila barrier epithelia. EMBO Rep. 2001;2:239–243. doi: 10.1093/embo-reports/kve048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodriguez A, Oliver H, Zou H, Chen P, Wang X, Abrams JM. Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily conserved death pathway. Nat Cell Biol. 1999;1:272–279. doi: 10.1038/12984. [DOI] [PubMed] [Google Scholar]
- Rutschmann S, Jung AC, Hetru C, Reichhart JM, Hoffmann JA, Ferrandon D. The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila. Immunity. 2000a;12:569–580. doi: 10.1016/s1074-7613(00)80208-3. [DOI] [PubMed] [Google Scholar]
- Rutschmann S, Jung AC, Zhou R, Silverman N, Hoffmann JA, Ferrandon D. Role of Drosophila IKKγ in a Toll-independent antibacterial immune response. Nat Immunol. 2000b;1:342–347. doi: 10.1038/79801. [DOI] [PubMed] [Google Scholar]
- Sakurai H, Miyoshi H, Toriumi W, Sugita T. Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation. J Biol Chem. 1999;274:10641–10648. doi: 10.1074/jbc.274.15.10641. [DOI] [PubMed] [Google Scholar]
- Sakurai H, Shigemori N, Hasegawa K, Sugita T. TGF-β-activated kinase 1 stimulates NF-κ B activation by an NF-κ B-inducing kinase-independent mechanism. Biochem Biophys Res Commun. 1998;243:545–549. doi: 10.1006/bbrc.1998.8124. [DOI] [PubMed] [Google Scholar]
- Shibuya H, Iwata H, Masuyama N, Gotoh Y, Yamaguchi K, Irie K, Matsumoto K, Nishida E, Ueno N. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J. 1998;17:1019–1028. doi: 10.1093/emboj/17.4.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shirakabe K, Yamaguchi K, Shibuya H, Irie K, Matsuda S, Moriguchi T, Gotoh Y, Matsumoto K, Nishida E. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem. 1997;272:8141–8144. doi: 10.1074/jbc.272.13.8141. [DOI] [PubMed] [Google Scholar]
- Silverman N, Zhou J, Stöven S, Pandey N, Hultmark D, Maniatis T. A Drosophila IkB kinase complex required for Relish cleavage and antibacterial immunity. Genes & Dev. 2000;14:2461–2471. doi: 10.1101/gad.817800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stöven S, Ando I, Kadalayil L, Engström Y, Hultmark D. Activation of the Drosophila NF-κB factor Relish by rapide endoproteolytic cleavage. EMBO Rep. 2000;1:347–352. doi: 10.1093/embo-reports/kvd072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takatsu Y, Nakamura M, Stapleton M, Danos MC, Matsumoto K, O'Connor MB, Shibuya H, Ueno N. TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development. Mol Cell Biol. 2000;20:3015–3026. doi: 10.1128/mcb.20.9.3015-3026.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tzou P, Ohresser S, Ferrandon D, Capovilla M, Reichhart JM, Lemaitre B, Hoffmann JA, Imler JL. Tissue-specific inducible expression of antimicrobial peptide genes in Drosophila surface epithelia. Immunity. 2000;13:737–748. doi: 10.1016/s1074-7613(00)00072-8. [DOI] [PubMed] [Google Scholar]
- Wang W, Zhou G, Hu MC, Yao Z, Tan TH. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor-β (TGF-β)-activated kinase (TAK1), a kinase mediator of TGF-β signal transduction. J Biol Chem. 1997;272:22771–22775. doi: 10.1074/jbc.272.36.22771. [DOI] [PubMed] [Google Scholar]
- Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science. 1995;270:2008–2011. doi: 10.1126/science.270.5244.2008. [DOI] [PubMed] [Google Scholar]